Ticker Symbol: HRTX
Heron Therapeutics Inc
$11.24 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0000818033
Company Profile
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. Heron is developing novel, patient-focused solutions that apply its innovative science and technologies to already-approved pharmacological agents for patients suffering from pain or cancer.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 4242 Campus Point Ct Ste 200
Website: herontx.com
CEO: Barry Quart
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.01
Change:
$0.02
(
2.90%)
Days Range: $0.93 - $1.02
Beta: 1.65
52wk. High: $4.32
52wk. Low: $0.60
Ytd. Change -57.84%
50 Day Moving Average: $1.02
200 Day Moving Average: $1.51
Shares Outstanding: 140759276
Valuation
Market Cap: 14.2B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A